US 8344126
Compositions and methods for inhibiting expression of XBP-1 gene
granted A61PA61P35/00
Quick answer
US patent 8344126 (Compositions and methods for inhibiting expression of XBP-1 gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P35/00